These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 6204335)

  • 1. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
    Geysen HM; Meloen RH; Barteling SJ
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):3998-4002. PubMed ID: 6204335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.
    Geysen HM; Barteling SJ; Meloen RH
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):178-82. PubMed ID: 2578661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A priori delineation of a peptide which mimics a discontinuous antigenic determinant.
    Geysen HM; Rodda SJ; Mason TJ
    Mol Immunol; 1986 Jul; 23(7):709-15. PubMed ID: 2432410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies.
    Carreño C; Roig X; Cairo J; Camarero J; Mateu MG; Domingo E; Giralt E; Andreu D
    Int J Pept Protein Res; 1992 Jan; 39(1):41-7. PubMed ID: 1378821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The delineation of peptides able to mimic assembled epitopes.
    Geysen HM; Rodda SJ; Mason TJ
    Ciba Found Symp; 1986; 119():130-49. PubMed ID: 2426049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
    Pfaff E; Mussgay M; Böhm HO; Schulz GE; Schaller H
    EMBO J; 1982; 1(7):869-74. PubMed ID: 6203738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.
    Mateu MG; Martínez MA; Rocha E; Andreu D; Parejo J; Giralt E; Sobrino F; Domingo E
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5883-7. PubMed ID: 2474821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.
    Krasko AG; Moshnikova AB; Kozhich AT; Tchikin LD; Ivanov VT; Vladyko AS; Lukashevich IS
    Arch Virol; 1990; 115(1-2):133-7. PubMed ID: 1701079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution.
    Schoofs PG; Geysen HM; Jackson DC; Brown LE; Tang XL; White DO
    J Immunol; 1988 Jan; 140(2):611-6. PubMed ID: 2447184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
    Houghten RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5131-5. PubMed ID: 2410914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus.
    Clarke BE; Carroll AR; Rowlands DJ; Nicholson BH; Houghten RA; Lerner RA; Brown F
    FEBS Lett; 1983 Jul; 157(2):261-4. PubMed ID: 6190676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
    Parry NR; Syred A; Rowlands DJ; Brown F
    Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
    Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
    Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence.
    Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.